Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BWAY.TA
- Price
- 1626.00
- Stock movement down
- -8.00 (-0.49%)
- Company name
- Brainsway Ltd
- Exchange
- (TA ,
- Currency
- ILA )
- Sector
- Healthcare >Medical Devices
- Market cap
- 61.18B
- Ent value
- 61.15B
- Price/Sales
- 1679.32
- Price/Book
- 1423.43
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 100623.73
- Forward P/E
- -
- PEG
- -
- EPS growth
- -20.16%
- 1 year return
- 61.79%
- 3 year return
- 10.60%
- 5 year return
- -2.73%
- 10 year return
- -6.95%
Last updated: 2025-04-12
DIVIDENDS
BWAY.TA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 100623.73 |
| Price to OCF | 7321.59 |
| Price to FCF | 10495.66 |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 1679.32 |
| Price to Book | 1423.43 |
| EV to Sales | 1678.63 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 37.63M |
| EPS (TTM) | 0.02 |
| FCF per share (TTM) | 0.17 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 36.43M |
| Gross profit (TTM) | 27.26M |
| Operating income (TTM) | 730.00K |
| Net income (TTM) | 608.00K |
| EPS (TTM) | 0.02 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 74.82% |
| Operating margin (TTM) | 2.00% |
| Profit margin (TTM) | 1.67% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 47.86M |
| Net receivables | 3.87M |
| Total current assets | 57.34M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 6.24M |
| Total assets | 65.63M |
| Accounts payable | 1.61M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 12.20M |
| Total liabilities | 22.65M |
| Shareholder's equity | 42.98M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 8.36M |
| Capital expenditures (TTM) | 2.53M |
| Free cash flow (TTM) | 5.83M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 1.41% |
| Return on Assets | 0.93% |
| Return on Invested Capital | 1.41% |
| Cash Return on Invested Capital | 13.56% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1702.00 |
| Daily high | 1702.00 |
| Daily low | 1612.00 |
| Daily Volume | 30K |
| All-time high | 21872.00 |
| 1y analyst estimate | 11.40 |
| Beta | 0.37 |
| EPS (TTM) | 0.02 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 6 May 2025 |
Downside potential
Loading...
Downside potential data
| BWAY.TA | S&P500 | |
| Current price drop from All-time high | -92.57% | -14.41% |
| Highest price drop | -98.73% | -56.47% |
| Date of highest drop | 9 May 2023 | 9 Mar 2009 |
| Avg drop from high | -74.33% | -11.07% |
| Avg time to new high | 115 days | 12 days |
| Max time to new high | 3889 days | 1805 days |
COMPANY DETAILS
Marketcap
61.18B
Marketcap category
Large-cap
Description
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
Employees
134
Website
Investor relations
-
SEC filings
CEO
Country
Israel
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
A Relative Strength Rating upgrade for Steris shows improving technical performance. Will it continue?
March 18, 2025
BrainsWay Ltd (BRSYF) reports a 27% revenue increase and outlines plans for continued growth and innovation in 2025.
March 12, 2025
Achieved record quarterly sales of $11.4 million in Q4 2024, an increase of 27% compared with Q4 2023 Full year 2024 revenue increased nearly 30% YoY to $41 million Exceeded full year 2024 operating i...
March 11, 2025
BURLINGTON, Mass. and JERUSALEM, March 04, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatm...
March 4, 2025
BWAY stock continues to struggle near its IPO price despite growth. With rising revenues, global expansion and valuation concerns, is it a buy, hold or sell before earnings?
February 25, 2025
BURLINGTON, Mass. and JERUSALEM, Israel, Feb. 24, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
February 24, 2025
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
February 17, 2025
Two More Stocks for your Aggressive Growth Stock Radar Screen.
February 5, 2025
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
January 22, 2025
Brainsway (BWAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength ...
January 22, 2025
Next page